Electrolyte Blood Press.  2015 Jun;13(1):7-16. 10.5049/EBP.2015.13.1.7.

Salt Sensitivity and Hypertension: A Paradigm Shift from Kidney Malfunction to Vascular Endothelial Dysfunction

• Choi HY
• Park HC
• Ha SK

• KMID: 2052337
• DOI: http://doi.org/10.5049/EBP.2015.13.1.7

Abstract

Hypertension is a complex trait determined by both genetic and environmental factors and is a major public health problem due to its high prevalence and concomitant increase in the risk for cardiovascular disease. With the recent large increase of dietary salt intake in most developed countries, the prevalence of hypertension increases tremendously which is about 30% of the world population. There is substantial evidence that suggests some people can effectively excrete high dietary salt intake without an increase in arterial BP, and another people cannot excrete effectively without an increase in arterial BP. Salt sensitivity of BP refers to the BP responses for changes in dietary salt intake to produce meaningful BP increases or decreases. The underlying mechanisms that promote salt sensitivity are complex and range from genetic to environmental influences. The phenotype of salt sensitivity is therefore heterogeneous with multiple mechanisms that potentially link high salt intake to increases in blood pressure. Moreover, excess salt intake has functional and pathological effects on the vasculature that are independent of blood pressure. Epidemiologic data demonstrate the role of high dietary salt intake in mediating cardiovascular and renal morbidity and mortality. Almost five decades ago, Guyton and Coleman proposed that whenever arterial pressure is elevated, pressure natriuresis enhances the excretion of sodium and water until blood volume is reduced sufficiently to return arterial pressure to control values. According to this hypothesis, hypertension can develop only when something impairs the excretory ability of sodium in the kidney. However, recent studies suggest that nonosmotic salt accumulation in the skin interstitium and the endothelial dysfunction which might be caused by the deterioration of vascular endothelial glycocalyx layer (EGL) and the epithelial sodium channel on the endothelial luminal surface (EnNaC) also play an important role in nonosmotic storage of salt. These new concepts emphasize that sodium homeostasis and salt sensitivity seem to be related not only to the kidney malfunction but also to the endothelial dysfunction. Further investigations will be needed to assess the extent to which changes in the sodium buffering capacity of the skin interstitium and develop the treatment strategy for modulating the endothelial dysfunction.

Keyword

Salt; Sensitivity; Hypertension; Kidney malfunction; Endothelial dysfunction

MeSH Terms

Arterial Pressure
Blood Pressure
Blood Volume
Cardiovascular Diseases
Developed Countries
Epithelial Sodium Channels
Glycocalyx
Homeostasis
Hypertension*
Kidney*
Mortality
Natriuresis
Negotiating
Phenobarbital
Phenotype
Prevalence
Public Health
Skin
Sodium
Water
Epithelial Sodium Channels
Phenobarbital
Sodium
Water

Reference

1. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure in 6 European countries, Canada, and the United States. JAMA. 2003; 289:2363–2369. PMID: 12746359.

2. Ambard L, Beaujard E. Causes de l=hypertension artérielle. Arch Gen Med. 1904; 1:520–533.

3. Kempner W. Treatment of hypertensive vascular disease with the rice diet. Am J Med. 1948; 4:545–577. PMID: 18909456.

4. Ball OT, Meneely GR. Observations on dietary sodium chloride. J Am Diet Assoc. 1957; 33:366–370. PMID: 13415846.

5. Dahl LK, Heine M, Tassinari L. Effects of chronic salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med. 1962; 115:1173–1190. PMID: 13883089.

6. Denton D, Weisinger R, Mundy NI, et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995; 1:1009–1016. PMID: 7489355.

7. MacGregor GA, Markandu ND, Best FE, et al. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982; 1:351–355. PMID: 6120346.

8. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 h urinary sodium and potassium excretion. BMJ. 1988; 297:319–328. PMID: 3416162.

9. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. JAMA. 1992; 267:1213–1220. PMID: 1586398.

10. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997; 157:657–667. PMID: 9080920.

11. Whelton PK, Appel LJ, Espeland MA, et al. for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998; 279:839–846. PMID: 9515998.

12. Sacks FM, Svetkey LP, Vollmer WM, et al. DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001; 344:3–10. PMID: 11136953.

13. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999; 282:2027–2034. PMID: 10591385.

14. Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001; 357:848–851. PMID: 11265954.

15. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow up of the trials of hypertension prevention (TOHP). BMJ. 2007; 334:885–888. PMID: 17449506.

16. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009; 339:b4567–b4576. PMID: 19934192.

17. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med. 1978; 64:193–198. PMID: 629267.

18. Luft FC, Rankin LI, Bloch R, et al. Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation. 1979; 60:697–706. PMID: 455628.

19. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986; 8(suppl 2):II127–II134. PMID: 3522418.

20. Luft FC, Weinberger MH. Sodium sensitivity and resistance of blood pressure: the role of the kidney and the renin-aldosterone axis. Kidney Int Suppl. 1987; 22:S234–S241. PMID: 3480991.

21. Giner V, Poch E, Bragulat E, et al. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension. 2000; 35:512–517. PMID: 10642351.

22. De la Sierra A, Lluch MM, Coca A, et al. Fluid, ionic and hormonal changes induced by high salt intake in saltsensitive and salt-resistant hypertensive patients. Clin Sci. 1996; 91:155–161. PMID: 8795438.

23. Lluch MM, De la Sierra A, Poch E, et al. Erythrocyte sodium transport, intraplatelet pH, and calcium concentration in salt sensitive hypertension. Hypertension. 1996; 27:919–925. PMID: 8613269.

24. Miyoshi A, Suzuki H, Fujiwara M, Masai M, Iwasaki T. Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens. 1997; 10:1083–1090. PMID: 9370377.

25. Bragulat E, De la Sierra A, Antonio MT, Coca A. Endothelial dysfunction in salt-sensitive hypertension. Hypertension. 2001; 37:444–448. PMID: 11230316.

26. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science. 1991; 252:1813–1816. PMID: 2063193.

27. Farquhar WB, Edwards DG, Jurkovitz CT, Weintraub WS. Dietary sodium and health. More than just blood pressure. J Am Coll Cardiol. 2015; 65:1042–1050. PMID: 25766952.

28. Kusch-Vihrog K, Oberleithner H. An emerging concept of vascular salt sensitivity. F1000 Biol Rep. 2012; 4:20–26. PMID: 23112808.

29. Strauss MB, Lamdin E, Smith WP, et al. Surfeit and deficit of sodium: a kinetic concept of sodium excretion. AMA Arch Intern Med. 1958; 102:527–536. PMID: 13582242.

30. Reineck JH, Stein JH. Regulation of sodium balance. In : Maxwell MH, Kleeman CR, editors. Clinical disorders of fluid and electrolyte metabolism. New York: McGraw-Hill;1980. p. 89–112.

31. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure: Age and pressure change over time. Hypertension. 1991; 18:67–71. PMID: 1860713.

32. Weinberger MH, Stegner JE, Fineberg NS. A comparison of two tests for the assessment of blood pressure responses to sodium. Am J Hypertens. 1993; 6:179–184. PMID: 8466703.

33. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996; 27:481–490. PMID: 8613190.

34. Luft FC, Weinberger MH. Heterogeneous responses to changes in dietary salt intake: the salt sensitivity paradigm. Am J Clin Nutr. 1997; 65:612S–617S. PMID: 9022556.

35. GenSalt Collaborative Research Group. GenSalt: rationale, design, methods and baseline characteristics of study participants. J Hum Hypertens. 2007; 21:639–646. PMID: 17443206.

36. Morimoto A, Uzu T, Fujii T, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997; 350:1734–1737. PMID: 9413464.

37. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001; 37:429–432. PMID: 11230313.

38. He J, Gu D, Chen J, et al. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens. 2009; 27:48–54. PMID: 19145767.

39. Gu D, Zhao Q, Chen J, et al. Reproducibility of Blood Pressure Responses to Dietary Sodium and Potassium Interventions. The GenSalt Study. Hypertension. 2013; 62:499–505. PMID: 23897070.

40. de Leeuw PW, Kroon AA. Salt and sensitivity. Hypertension. 2013; 62:461–462. PMID: 23897072.

41. Borst JG, Borst-de Geus A. Hypertension explained by Starling's theory of circulatory homeostasis. Lancet. 1963; 1:677–682. PMID: 14014100.

42. Dahl LK, Heine M, Thompson K. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res. 1974; 34:94–101. PMID: 4588315.

43. Guyton AC, Coleman TG. Long-term regulation of the circulation: inter-relationship with body fluid volumes. In : Reeve E, Guyton AC, editors. Physical basis of circulatory transport: regulation and exchange. Philadelphia: Saunders;1967. p. 179–201.

44. Cowley AW Jr. Long-term control of arterial blood pressure. Physiol Rev. 1992; 72:23l–300.

45. Lifton R, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001; 104:545–556. PMID: 11239411.

46. Mu S, Shimosawa T, Ogura S, et al. Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med. 2011; 17:573–580. PMID: 21499270.

47. Nishimoto M, Fujita T. Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways. Am J Physiol Renal Physiol. 2015; 308:F377–F387. PMID: 25520008.

48. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol. 2000; 278:F585–F595. PMID: 10751219.

49. Titze J, Bauer K, Schafflhuber M, et al. Internal sodium balance in DOCA-salt rats: A body composition study. Am J Physiol Renal Physiol. 2005; 289:F793–F802. PMID: 15914779.

50. Titze J, Shakibaei M, Schafflhuber M, et al. Glycosa minoglycan polymerization may enable osmotically inactive Na⁺ storage in the skin. Am J Physiol Heart Circ Physiol. 2004; 287:H203–H208. PMID: 14975935.

51. Machnik A, Neuhofer W, Jantsch J, et al. Macrophages regulate salt dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009; 15:545–552. PMID: 19412173.

52. Machnik A, Dahlmann A, Kopp C, et al. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension. 2010; 55:755–761. PMID: 20142563.

53. Oberleithner H. Two barriers for sodium in vascular endothelium? Ann Med. 2012.

54. Potter DR, Jiang J, Damiano ER. The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ Res. 2009; 104:1318–1325. PMID: 19443840.

55. Chappell D, Jacob M, Paul O, et al. The glycocalyx of the human umbilical vein endothelial cell: An impressive structure ex vivo but not in culture. Circ Res. 2009; 104:1313–1317. PMID: 19423849.

56. Oberleithner H, Peters W, Kusche-Vihrog K, et al. Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch. 2011; 462:519–528. PMID: 21796337.

57. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007; 104:16281–16286. PMID: 17911245.

58. Korte S, Wiesinger A, Straeter AS, Peters W, Oberleithner H, Kusche-Vihrog K. Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis. Pflugers Arch. 2012; 463:269–278. PMID: 22057584.

59. Olde Engberink RH, Rorije NM, Homan van der Heide JJ, van den Born BJ, Vogt L. Role of the vascular wall in sodium homeostasis and salt sensitivity. J Am Soc Nephrol. 2015; 26:777–783. PMID: 25294232.

60. Korte S, Sträter AS, Drüppel V, Oberleithner H, Jeggle P, Grossmann C, et al. Feedforward activation of endothelial ENaC by high sodium. FASEB J. 2014; 28:4015–4025. PMID: 24868010.

61. Lang F. Stiff endothelial cell syndrome in vascular inflammation and mineralocorticoid excess. Hypertension. 2011; 57:146–147. PMID: 21149825.